查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614347

Finasteride市場：依適應症、通路分類 - 2025-2030 年全球預測

Finasteride Market by Indication (Androgenetic Alopecia, Benign Prostatic Hyperplasia), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Finasteride市值為1.1968億美元，預計2024年將達到1.2288億美元，複合年成長率為2.81%，預計到2030年將達到1.454億美元。

Finasteride是一種主要用於治療良性前列腺增生（BPH）和雄性禿的藥物，脫髮症在泌尿系統和皮膚科的雙重治療用途而受到關注。Finasteride的需求是由於與男性老化相關的良性前列腺增生的增加以及對毛髮生長劑的需求不斷成長。其用途包括用於治療 BPH 的口服錠劑和用於治療脫髮的局部製劑。最終用途範圍涵蓋醫療保健部門，例如醫院、專科診所和零售藥房，所有這些對於向民眾分發Finasteride至關重要。市場成長的主要驅動力是人口老化、雄性禿脫髮症的增加、醫療保健意識的提高以及配方技術的進步。最新的成長機會包括擴大地理覆蓋範圍，特別是在醫療基礎設施正在改善的亞太地區和拉丁美洲。公司可以利用這一點，透過進行策略性合併來擴大其市場佔有率。然而，專利到期和替代治療的可用性也面臨增加市場競爭的挑戰。此外，性功能障礙等副作用可能會限制接受度。各地區的監管障礙也帶來了挑戰。有前景的創新領域包括開發先進的給藥系統以提高藥物療效並最大限度地減少副作用，探索聯合治療以提高治療效果，以及製定有針對性的行銷策略，其中包括人工智慧主導分析的整合。此外，對Finasteride治療疾病的遺傳易感性研究的更多關注可能會開拓新的細分市場。總體而言，Finasteride市場是動態的，具有透過策略擴張和創新來實現成長的潛力，但應採取平衡的方法，透過仔細評估監管環境和消費者的看法來最大限度地發揮市場潛力。

主要市場統計
基準年[2023] 11968萬美元
預計年份 [2024] 12288萬美元
預測年份 [2030] 1.454 億美元
複合年成長率（%） 2.81%

市場動態：揭示快速發展的Finasteride市場的關鍵市場洞察

Finasteride市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 雄性禿和脫髮症護腺疾病的盛行率增加
    • 增加市場准入的支持性監管政策
  • 市場限制因素
    • 原料短缺影響生產擴充性
  • 市場機會
    • Finasteride生產技術的進步
    • Finasteride的治療用途大幅擴展
  • 市場挑戰
    • 缺乏技術純熟勞工

波特的五力：駕馭非Finasteride市場的策略工具

波特的五力架構是了解Finasteride市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對Finasteride市場的影響

外部宏觀環境因素在塑造Finasteride市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解非Finasteride市場的競爭狀況

對Finasteride市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣Finasteride市場供應商績效評估

FPNV定位矩陣是評估Finasteride市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製您在非Finasteride市場的成功之路

Finasteride市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 男性型脫髮症和攝護腺疾病增加
      • 增加市場准入的支持性監管政策
    • 抑制因素
      • 原料短缺影響生產擴充性
    • 機會
      • Finasteride生產技術的進步
      • Finasteride的治療用途大幅擴展
    • 任務
      • 缺乏技術純熟勞工
  • 市場區隔分析
    • 適應症：Finasteride在男性型脫髮症的採用率很高，使其成為長期治療的選擇
    • 通路：網路藥局的出現成為尋求隱私和便利的病患的便利選擇
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 非Finasteride市場的適應症

  • 雄性脫髮症
  • 良性攝護腺增生

第7章Finasteride市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 美洲非Finasteride市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區Finasteride市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲Finasteride市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zydus 獲得美國 FDA核准Finasteride和他達拉非膠囊
    • Zydus Lifesciences 透過收購英國Liqmeds Group 擴大全球影響力
    • Bluewater Vaccines 收購 Verus Pharmaceuticals 的 Entadfi 膠囊部門
  • 戰略分析和建議

公司名單

  • Accord Healthcare US. by Intas Pharmaceuticals
  • Apotex Inc.
  • Aurobindo Pharma USA, Inc.
  • Camber Pharmaceuticals, Inc. by Hetero Labs Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Endo, Inc.
  • Hanmi Pharmaceutical Co., LTD.
  • Merck KGaA
  • Niksan Life Sciences Private Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals USA, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Veru Inc.
  • Viatris Inc.
  • WELLONA PHARMACEUTICAL PRIVATE LIMITED
  • Zydus Group.
Product Code: MRR-CD5A9334D4CB

The Finasteride Market was valued at USD 119.68 million in 2023, expected to reach USD 122.88 million in 2024, and is projected to grow at a CAGR of 2.81%, to USD 145.40 million by 2030.

Finasteride, a medication primarily used to treat benign prostatic hyperplasia (BPH) and male pattern baldness, has garnered attention due to its dual therapeutic applications in urology and dermatology. The necessity for Finasteride arises from the growing incidence of BPH in aging males and increased demand for hair regrowth solutions. Its application extends to both oral tablets for BPH management and topical formulations for hair loss treatment. End-use scope encompasses healthcare sectors like hospitals, specialty clinics, and retail pharmacies, all pivotal in dispensing Finasteride to the population. Market growth is largely driven by the aging demographic trend, increasing prevalence of androgenetic alopecia, and rising healthcare awareness, coupled with technological advancements in drug formulations. Latest opportunities for growth include expanding geographic access, especially in Asia-Pacific and Latin America, where healthcare infrastructure is improving. Companies could capitalize on this by engaging in strategic mergers to expand market presence. However, the Finasteride market is challenged by patent expirations and the availability of alternative therapies, which increase market competition. Additionally, side effects such as sexual dysfunction may limit its acceptance. Regulatory hurdles across various regions also pose challenges. Promising areas of innovation include developing advanced delivery systems to improve the drug's efficacy and minimize side effects, exploring combination therapies for enhanced outcomes, and integrating AI-driven analytics for targeted marketing strategies. Furthermore, an increased focus on research concerning genetic predispositions to conditions treated with Finasteride could unlock new market segments. Overall, the Finasteride market is dynamic, with potential for growth through strategic expansion and innovation, yet it necessitates careful navigation of regulatory landscapes and consumer perceptions, ensuring a balanced approach to leverage its full market potential.

KEY MARKET STATISTICS
Base Year [2023] USD 119.68 million
Estimated Year [2024] USD 122.88 million
Forecast Year [2030] USD 145.40 million
CAGR (%) 2.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Finasteride Market

The Finasteride Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of androgenetic alopecia and prostate disorders
    • Supportive regulatory policies enhancing market accessibility
  • Market Restraints
    • Raw material scarcity impacting production scalability
  • Market Opportunities
    • Advancements in production technologies for finasteride
    • Significant expansion of finasteride in therapeutic applications
  • Market Challenges
    • Shortage of skilled workforce

Porter's Five Forces: A Strategic Tool for Navigating the Finasteride Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Finasteride Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Finasteride Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Finasteride Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Finasteride Market

A detailed market share analysis in the Finasteride Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Finasteride Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Finasteride Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Finasteride Market

A strategic analysis of the Finasteride Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Finasteride Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare US. by Intas Pharmaceuticals, Apotex Inc., Aurobindo Pharma USA, Inc., Camber Pharmaceuticals, Inc. by Hetero Labs Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo, Inc., Hanmi Pharmaceutical Co., LTD., Merck KGaA, Niksan Life Sciences Private Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Ltd., Veru Inc., Viatris Inc., WELLONA PHARMACEUTICAL PRIVATE LIMITED, and Zydus Group..

Market Segmentation & Coverage

This research report categorizes the Finasteride Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Androgenetic Alopecia and Benign Prostatic Hyperplasia.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of androgenetic alopecia and prostate disorders
      • 5.1.1.2. Supportive regulatory policies enhancing market accessibility
    • 5.1.2. Restraints
      • 5.1.2.1. Raw material scarcity impacting production scalability
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in production technologies for finasteride
      • 5.1.3.2. Significant expansion of finasteride in therapeutic applications
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled workforce
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: High adoption of finasteride in androgenetic alopecia a long-term treatment option
    • 5.2.2. Distribution Channel: Emergence of online pharmacies as a convenient option for patients seeking privacy and ease
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Finasteride Market, by Indication

  • 6.1. Introduction
  • 6.2. Androgenetic Alopecia
  • 6.3. Benign Prostatic Hyperplasia

7. Finasteride Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Finasteride Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Finasteride Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Finasteride Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Zydus Secures USFDA Approval for Finasteride and Tadalafil Capsules
    • 11.3.2. Zydus Lifesciences Expands Its Global Reach with Acquisition of UK-Based Liqmeds Group
    • 11.3.3. Blue Water Vaccines Acquires Verus Pharmaceuticals' Entadfi Capsules Division
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accord Healthcare US. by Intas Pharmaceuticals
  • 2. Apotex Inc.
  • 3. Aurobindo Pharma USA, Inc.
  • 4. Camber Pharmaceuticals, Inc. by Hetero Labs Limited
  • 5. Cipla Limited
  • 6. Dr. Reddy's Laboratories Ltd.
  • 7. Endo, Inc.
  • 8. Hanmi Pharmaceutical Co., LTD.
  • 9. Merck KGaA
  • 10. Niksan Life Sciences Private Limited
  • 11. Sun Pharmaceutical Industries Limited
  • 12. Teva Pharmaceuticals USA, Inc.
  • 13. Torrent Pharmaceuticals Ltd.
  • 14. Veru Inc.
  • 15. Viatris Inc.
  • 16. WELLONA PHARMACEUTICAL PRIVATE LIMITED
  • 17. Zydus Group.

LIST OF FIGURES

  • FIGURE 1. FINASTERIDE MARKET RESEARCH PROCESS
  • FIGURE 2. FINASTERIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FINASTERIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FINASTERIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023